Vivani Medical (VANI) Competitors $1.18 0.00 (0.00%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VANI vs. SMTI, ZYXI, LUNG, ELMD, CATX, PROF, DRTS, SKIN, KRMD, and SGHTShould you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Sanara MedTech (SMTI), Zynex (ZYXI), Pulmonx (LUNG), Electromed (ELMD), Perspective Therapeutics (CATX), Profound Medical (PROF), Alpha Tau Medical (DRTS), Beauty Health (SKIN), KORU Medical Systems (KRMD), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry. Vivani Medical vs. Sanara MedTech Zynex Pulmonx Electromed Perspective Therapeutics Profound Medical Alpha Tau Medical Beauty Health KORU Medical Systems Sight Sciences Vivani Medical (NASDAQ:VANI) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk. Does the MarketBeat Community favor VANI or SMTI? Sanara MedTech received 16 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformVivani MedicalOutperform Votes2100.00% Underperform VotesNo VotesSanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% Do analysts prefer VANI or SMTI? Vivani Medical presently has a consensus price target of $3.00, indicating a potential upside of 154.24%. Sanara MedTech has a consensus price target of $44.00, indicating a potential upside of 30.64%. Given Vivani Medical's higher possible upside, equities research analysts plainly believe Vivani Medical is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer VANI or SMTI? In the previous week, Vivani Medical had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 2 mentions for Vivani Medical and 0 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.00 beat Vivani Medical's score of -0.24 indicating that Sanara MedTech is being referred to more favorably in the news media. Company Overall Sentiment Vivani Medical Neutral Sanara MedTech Neutral Do insiders and institutionals have more ownership in VANI or SMTI? 6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 44.3% of Vivani Medical shares are owned by insiders. Comparatively, 54.1% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, VANI or SMTI? Vivani Medical has a beta of 3.16, indicating that its stock price is 216% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Which has preferable valuation and earnings, VANI or SMTI? Sanara MedTech has higher revenue and earnings than Vivani Medical. Sanara MedTech is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivani MedicalN/AN/A-$25.65M-$0.45-2.62Sanara MedTech$78.06M3.77-$4.30M-$0.99-34.02 Is VANI or SMTI more profitable? Vivani Medical has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Vivani Medical's return on equity.Company Net Margins Return on Equity Return on Assets Vivani MedicalN/A -102.42% -49.21% Sanara MedTech -10.71%-19.86%-10.91% SummarySanara MedTech beats Vivani Medical on 8 of the 15 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VANI vs. The Competition Export to ExcelMetricVivani MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$69.90M$3.01B$5.12B$9.07BDividend YieldN/A1.75%4.91%4.22%P/E Ratio-2.6216.6491.3417.19Price / SalesN/A50.151,116.59116.80Price / CashN/A39.9142.6437.86Price / Book2.883.724.794.78Net Income-$25.65M$89.83M$120.07M$225.60M7 Day Performance-9.92%-1.82%-1.89%-1.24%1 Month Performance-11.28%0.28%11.45%3.36%1 Year Performance26.88%4.10%30.61%16.58% Vivani Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VANIVivani Medical2.7875 of 5 stars$1.18flat$3.00+154.2%+34.6%$69.90MN/A-2.6220News CoverageSMTISanara MedTech1.9969 of 5 stars$33.83-2.4%$44.00+30.1%-14.5%$295.67M$64.99M-35.0060ZYXIZynex3.4977 of 5 stars$8.45+3.8%$14.00+65.7%-21.1%$269.13M$184.32M54.271,100Positive NewsLUNGPulmonx2.6733 of 5 stars$6.20+1.6%$12.75+105.6%-49.2%$244.83M$79.30M-4.15250ELMDElectromedN/A$28.42+0.9%N/A+158.0%$240.38M$57.06M39.14174CATXPerspective Therapeutics3.3599 of 5 stars$3.48flat$15.14+335.1%N/A$235.21M$1.43M0.00116Positive NewsPROFProfound Medical2.5362 of 5 stars$7.22-2.4%$13.75+90.4%-12.8%$216.82M$7.20M-5.52150High Trading VolumeDRTSAlpha Tau Medical1.9713 of 5 stars$3.10+1.0%$8.00+158.1%+10.3%$216.76MN/A-7.1480SKINBeauty Health1.6194 of 5 stars$1.56-1.3%$2.55+63.5%-54.1%$193.63M$398M-3.761,030KRMDKORU Medical Systems1.3182 of 5 stars$4.20-2.3%$4.13-1.8%+74.0%$192.53M$28.52M-17.2080SGHTSight Sciences3.389 of 5 stars$3.65+2.0%$5.12+40.3%+7.2%$185.27M$81.06M-3.51210News Coverage Related Companies and Tools Related Companies SMTI Competitors ZYXI Competitors LUNG Competitors ELMD Competitors CATX Competitors PROF Competitors DRTS Competitors SKIN Competitors KRMD Competitors SGHT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VANI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
